21 CFR Part 314
APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG
June 25, 2020
Subpart
F
[Reserved]
Subpart
G
Miscellaneous Provisions
Subpart
A
General Provisions
Subpart
B
Applications
Subpart
C
Abbreviated Applications
Subpart
D
FDA Action on Applications and Abbreviated Applications
Subpart
E
Hearing Procedures for New Drugs
Subpart
H
Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses
Subpart
I
Approval of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible